What Is Menopausal Hair Loss?
Menopausal hair loss refers to the diffuse thinning and increased shedding that many women experience during perimenopause and the years following the menopause. It is not a single condition but rather the result of overlapping biological processes, primarily the decline in oestrogen and the increased relative influence of androgens on hair follicles. Unlike the temporary shedding that follows acute events such as illness or childbirth, menopausal hair loss can be a slow, progressive process that continues without intervention.
The condition is far more common than most women are led to expect. Research suggests that up to fifty percent of women experience noticeable hair thinning by their mid-fifties, yet hair loss during and after the menopause receives considerably less clinical attention than other menopausal symptoms. Many women are told simply that it is a normal part of ageing, without being given any meaningful discussion of the mechanisms involved or the options available to them. It is not trivial, and it is not untreatable.
At Regener8 Aesthetics in Selly Oak, Birmingham, we see a significant number of women across the perimenopausal and menopausal range who are concerned about changes to their hair. Our approach combines a thorough clinical assessment with an honest discussion of what is driving the thinning, whether any underlying factors can be identified and addressed, and which treatments are most likely to be useful given your specific pattern and history.
Menopausal hair loss is driven by the decline in oestrogen during perimenopause and menopause, which reduces the protective effect on hair follicles and increases the relative influence of androgens. The result is often a combination of diffuse shedding (telogen effluvium) and progressive follicle miniaturisation (androgenetic alopecia). The condition affects a large proportion of women and, unlike some menopausal symptoms, does not resolve on its own without intervention.
Symptoms of Menopausal Hair Loss
The presentation of menopausal hair loss differs from male pattern baldness in both pattern and character. Women typically experience the following:
- Gradual diffuse thinning across the top of the scalp, the crown, and along the parting, rather than a receding hairline
- A widening parting that becomes increasingly visible over months or years
- Reduced overall hair volume, particularly noticeable when styling or putting hair up
- Increased daily hair shedding, with more hair than usual accumulating on the pillow, in the brush, or in the shower drain
- Hair that appears finer, weaker, or less elastic than previously, breaking more easily
- A reduction in hair density that may be gradual enough to be noticed first by the woman herself rather than by others
- In some cases, thinning at the temples or a slight frontal recession, though full hairline loss as seen in men is uncommon
- Scalp showing through hair in certain lighting conditions where it previously did not
The psychological impact of these changes should not be underestimated. Hair thinning that coincides with other menopausal changes, including shifts in skin texture, body composition, and mood, can compound the sense of loss associated with this life stage. At Regener8, we take both the clinical and personal dimensions of this experience seriously.
Causes of Menopausal Hair Loss
The primary driver is the decline in oestrogen that characterises perimenopause and menopause. Oestrogen plays a significant protective role for hair follicles: it prolongs the anagen (growth) phase of the hair cycle, counterbalances the miniaturising effect of androgens, and supports the overall health of the follicle environment. As oestrogen levels fall, these protective mechanisms weaken, and follicles become more sensitive to the androgens that are present in all women (primarily testosterone and its more potent derivative, dihydrotestosterone, or DHT).
The result is typically a combination of two processes occurring simultaneously:
- Telogen effluvium: The hormonal disruption of perimenopause can push follicles out of the growth phase and into the resting phase prematurely, causing a period of increased shedding. This component may fluctuate alongside other perimenopausal symptoms and can partly recover as hormones stabilise.
- Androgenetic alopecia (female pattern hair loss): The increased androgen sensitivity of follicles causes progressive miniaturisation, where each successive hair cycle produces a shorter, finer hair until production eventually ceases in the affected follicle. This component is typically progressive without treatment.
Several additional factors can compound or accelerate the process:
- Thyroid dysfunction: Thyroid conditions, both hypothyroidism and hyperthyroidism, are more common in women over forty and can independently cause significant hair loss. They should always be excluded through blood testing.
- Iron and ferritin deficiency: Even without anaemia, low ferritin levels are associated with increased hair shedding. Dietary changes during or around the menopause, and the cessation of monthly blood loss, can affect iron balance in complex ways.
- Vitamin D and B12 deficiency: Both are common in the UK population and both have an established association with hair loss.
- Chronic stress: The psychosocial demands of midlife can compound hair loss through the stress hormone pathway, though this tends to be a secondary rather than primary driver.
Many women have a genetic predisposition to female pattern hair loss that is held in check by oestrogen's protective influence for most of their reproductive years. The menopause removes this protection, effectively unmasking a tendency that was always present in the follicle biology. This is why menopausal hair loss and female pattern hair loss are so closely linked, and why treatments targeting androgen sensitivity at the follicle level can be relevant for women in this group.
Who Is Affected?
Menopausal hair loss is considerably more prevalent than public awareness reflects. Studies suggest that around forty to fifty percent of women experience clinically noticeable hair thinning by their mid-fifties, with onset often beginning during the perimenopausal transition rather than after the menopause itself. Perimenopause, which may last several years before the final menstrual period, is frequently the period when women first notice changes to hair density, volume, or shedding rates.
The following factors may influence who experiences a more pronounced episode:
- A personal or family history of female pattern hair loss significantly increases the likelihood of menopausal hair thinning, as oestrogen's protective effect is removed
- Women who experienced significant postpartum hair loss may be more aware of follicle sensitivity to hormonal change, and may notice menopausal changes earlier
- Nutritional deficiencies, particularly iron, ferritin, and vitamin D, are common in this age group and can amplify hormonal hair loss
- Thyroid conditions, which are more prevalent in women over forty, can both mimic and compound menopausal hair loss
- Chronic stress, whether occupational or personal, may accelerate the process through cortisol's interaction with the hair growth cycle
- Women who experience an earlier or more abrupt menopause, including surgical menopause, may notice more sudden or pronounced hair changes due to the rapidity of the oestrogen decline
It is worth noting that the psychological impact of menopausal hair loss can be significant and is frequently compounded by other menopausal symptoms affecting appearance and wellbeing. Women should feel entitled to seek assessment and support for this symptom rather than accepting it as an inevitable and untreatable part of ageing.
Diagnosis and Assessment
A proper assessment of menopausal hair loss matters for two reasons: first, to confirm that the menopause is indeed the primary driver rather than a separate and potentially treatable condition such as thyroid disease; and second, to characterise the pattern of loss accurately so that the most appropriate treatment approach can be identified.
At Regener8 Aesthetics, a consultation for menopausal hair loss would typically involve:
- A detailed history covering the timeline of hair changes, menopausal symptoms, menstrual history, and any current medications or supplements
- A visual scalp assessment to characterise the pattern of thinning and estimate the degree of follicle involvement
- Discussion of relevant blood tests: a useful initial panel includes ferritin, full blood count, thyroid-stimulating hormone (TSH), vitamin D, and B12. These are arranged through your GP, and we will discuss your results and their implications at your appointment
- Consideration of whether an underlying predisposition to androgenetic alopecia is present, and what this means for treatment planning
- An honest and detailed discussion of treatment options, expected outcomes, and realistic timescales
The distinction between thyroid-related hair loss and menopausal hair loss is particularly important. Hypothyroidism causes diffuse shedding that closely resembles the menopausal pattern, and both conditions occur with increased frequency in midlife women. A TSH blood test is a simple and reliable way to identify thyroid involvement. If thyroid dysfunction is identified, treatment through your GP will often improve hair density as a secondary effect, and this should be addressed before or alongside any scalp-directed treatments.
Evidence-Based Treatments
The most appropriate treatment approach for menopausal hair loss depends on the pattern and severity of thinning, whether nutritional or thyroid factors are contributing, and the individual's priorities and preferences. A combination approach is frequently most effective.
First-Line Approaches
Nutritional assessment and correction is a reasonable first step for all women with menopausal hair loss. Blood tests to check ferritin, vitamin D, B12, and thyroid function can identify deficiencies that are independently treatable and that, if left unaddressed, will limit the response to other interventions. Eating a diet rich in protein, iron, zinc, and B vitamins supports the follicle environment. A postnatal supplement is not appropriate here; a targeted supplement addressing any specific identified deficiencies, taken alongside a varied diet, is more useful.
Medical and Hormonal Options
Topical minoxidil is the most evidence-based pharmacological treatment for female pattern hair loss and is available over the counter in a two-percent concentration. It requires consistent daily application and is effective only for as long as it is used; stopping typically leads to regression within months. Higher concentrations and oral formulations are available but would require discussion with a medical professional. HRT (Hormone Replacement Therapy), prescribed through a GP or menopause specialist on the basis of broader menopausal health considerations, may indirectly benefit hair by restoring the protective oestrogen environment. If HRT is something you are considering, this is a conversation to have with your GP. At Regener8, we can discuss scalp-directed treatments that complement any hormonal management.
PRP Therapy
PRP (Platelet-Rich Plasma) therapy concentrates your own platelets, which are rich in growth factors, and delivers them directly into the scalp at the level of the hair follicles. There is a growing body of evidence supporting PRP for androgenetic alopecia in both men and women, which is the dominant pattern underlying most menopausal hair loss. The growth factors in PRP are thought to stimulate follicle activity, improve scalp microcirculation, and support follicles that are miniaturising but have not yet permanently closed. Results vary between individuals and are most meaningful in women whose follicles are still biologically active. PRP is generally well tolerated and does not interact with HRT or nutritional supplements. An initial course of three sessions is typical, followed by periodic maintenance.
Microneedling
Scalp microneedling creates controlled micro-channels in the dermis that trigger a local healing and regenerative response, stimulating the production of growth factors and improving blood supply to the follicles. It is used as both a standalone treatment and in combination with PRP, where it may enhance the penetration and effect of the applied plasma. Evidence for microneedling in female pattern hair loss is emerging, and it is a well-tolerated option for women seeking a non-pharmacological approach.
Nutrition and Lifestyle
Beyond addressing identified deficiencies, broader nutritional choices support scalp and follicle health. Adequate protein intake (hair is primarily composed of keratin, a protein) is fundamental. Oily fish, eggs, nuts, seeds, and leafy greens provide a range of micronutrients relevant to hair health. Chronic alcohol consumption and smoking have both been associated with worsened hair loss and are worth reducing where possible. Stress management, though unlikely to reverse established follicle miniaturisation on its own, may help moderate the telogen effluvium component of menopausal hair loss.
When Treatment May Not Be Appropriate
Active scalp infections, certain autoimmune scalp conditions, and recent significant illness may mean that some treatments should be delayed. Women with blood disorders or who are taking anticoagulant medication would need medical clearance before PRP. All of this is assessed at consultation, and there is never any pressure to proceed with treatment at that appointment.
Book a £25 consultation at Regener8 Aesthetics in Selly Oak, Birmingham. We will assess your hair loss, discuss the contributing factors, and outline the treatment options most relevant to your situation. Fully redeemable against any treatment within 30 days. Available in English, Farsi and Russian.
Finance available, subject to approval, via our Payl8r finance partner.
Why Choose Regener8 Aesthetics?
Regener8 Aesthetics is a boutique clinic in Selly Oak, Birmingham, specialising in regenerative and evidence-based aesthetic treatments. Hair restoration is a core part of our offering, and menopausal hair loss is one of the most frequent concerns we assess. We do not apply a standard protocol to every woman who walks through the door; each consultation is individual, unhurried, and based on an honest reading of your specific situation.
We understand that menopausal hair loss sits within a broader context. The perimenopausal and menopausal years can bring significant changes to skin, body composition, mood, and energy, and hair thinning during this period can feel like another unwelcome change at an already challenging time. We take the psychological weight of that seriously. Our consultations are conducted with the understanding that the emotional impact of hair loss matters, not just the clinical picture.
When treatment is appropriate, we offer PRP hair restoration and scalp microneedling, both performed by trained practitioners in a proper clinical environment. We use a rigorous centrifugation protocol for PRP preparation and set realistic expectations from the outset. We will never overstate what treatment can achieve or create false urgency around a decision. Your results are monitored over time, and your programme is adjusted based on your individual response.
We are pleased to offer consultations in English, Farsi (Persian), and Russian, reflecting the diversity of the communities we serve. Clients travel to us from across Birmingham including Harborne, Edgbaston, Bournville, Stirchley, Kings Heath, Moseley, Northfield, Bearwood, Quinton, Halesowen, Solihull, and Sutton Coldfield.
Our £25 consultation fee is fully redeemable against any treatment booked within 30 days. There is no obligation to proceed at that appointment. The consultation exists to give you clear, informed answers about what is happening with your hair and what can realistically be done about it.
- Menopausal hair loss is driven by the decline in oestrogen, which reduces follicle protection and increases androgen sensitivity, resulting in a combination of diffuse shedding and progressive follicle miniaturisation.
- Unlike some menopausal symptoms, hair thinning driven by androgenetic alopecia does not resolve on its own; earlier assessment and treatment tends to produce better outcomes than waiting.
- Thyroid dysfunction, iron deficiency, and vitamin D and B12 deficiency can all worsen or mimic menopausal hair loss and should be excluded through blood testing before treatment is pursued.
- PRP therapy and scalp microneedling have growing evidence for the androgenetic pattern underlying menopausal hair thinning, and can be used alongside nutritional optimisation and, where relevant, topical minoxidil.
- HRT may indirectly support hair health by restoring the oestrogen environment; the appropriateness of HRT for you is a decision for your GP, and scalp-directed treatments at Regener8 can complement any hormonal management you are already receiving.